Search
for
Sort by
Research 31–60 of 142
- Contemporary drug synthesis
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Recent advances in treatment for Benign Prostatic Hyperplasia
- Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis
- Lower urinary tract symptoms (LUTS): The role of medications in improvement of quality of life
- Comment on ‘Androgenetic alopecia is associated with increased scalp hardness’: role of phosphodiesterase inhibitors?
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Adverse effects of common medications on male fertility
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Common urologic diseases in older men and their treatment: how they impact fertility
- Ottawa, Ontario, Canada, February 13–16, 2013
- Systematic review: interventions in sickle cell disease-related priapism in reducing overall morbidity, recurrence, and side effects
- Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Identification of Potential Cytochrome p450c 17 Alpha Inhibitors for the Treatment of PCOS via Scaffold Hopping and Fragment-Based De-Novo Drug Design
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
- Diseases of the Canine Prostate Gland
- Dutasteride